AI Insight: Zimmer Biomet’s current price of $97.51 is significantly below its PERT-weighted fair value of $261.67, indicating a substantial implied upside of 168%. Valuation confidence is high, supported by multiple methods, while Monte Carlo analysis shows zero downside below current price and high volatility with a wide value range. Financial health reveals moderate leverage and liquidity but lower profitability and growth, signaling risk alongside potential opportunity.